Yoshiyuki Aikawa - 28 Apr 2026 Form 4 Insider Report for SBC Medical Group Holdings Inc (SBC)

Reporting relationship: Chairman and CEO, Director, 10%+ Owner
Issuer ticker: SBC
Reported as of: 28 Apr 2026
Net transaction value: -$1,405,462
SEC form: 4
Accepted by SEC: 29 Apr 2026, 21:38:46 UTC
Prior SEC filing: 23 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Yuya Yoshida, Attorney-in-Fact

Key filing fact

Yoshiyuki Aikawa filed Form 4 for SBC Medical Group Holdings Inc (SBC) on 29 Apr 2026.

Key facts

This page summarizes Yoshiyuki Aikawa's Form 4 filing for SBC Medical Group Holdings Inc (SBC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 29 Apr 2026, 21:38.

Change

Previous filing in this sequence was filed on 23 Apr 2026.
Current net transaction value: -$1,405,462.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002037003 Primary reporting owner

Aikawa Yoshiyuki

Relationship: Chairman and CEO, Director, 10%+ Owner
Address: C/O SBC MEDICAL GROUP HOLDINGS INC, 200 SPECTRUM CENTER DR., SUITE 300, IRVINE
Signature: /s/ Yuya Yoshida, Attorney-in-Fact
Signature date: 29 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SBC transaction

Common Stock

Sale

Transaction value: $1,405,462
Shares: -465,000
Change %: -0.59%
Price: $3.02
Shares after: 78,839,460
Date: 28 Apr 2026
Ownership: Direct
Footnotes: F1

SBC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 861,600
Date: 28 Apr 2026
Ownership: See Footnote
Footnotes: F2

SBC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,000,000
Date: 28 Apr 2026
Ownership: See Footnote
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The price of $3.0225 represents the net price received per share of common stock of SBC Medical Group Holdings Incorporated ("SBC shares"), which were sold by the Reporting Person, on the closing date of April 28, 2026, pursuant to the underwriters' option to purchase additional shares in connection with an underwritten public offering that initially closed on April 21, 2026.

Footnote F2

The 861,600 SBC shares reported as indirectly beneficially owned by the Reporting Person through Aikawa Equity Management Co., Ltd. ("AEM") reflects the Reporting Person's indirect interest that he may be deemed to have shared beneficial ownership over for purposes of Section 16 of the Securities Exchange Act of 1934, as amended. The Reporting Person owns 8,616 shares of AEM, which directly holds 5,284,500 SBC shares, and each share of AEM corresponds to one hundred SBC shares. The Reporting Person does not control AEM, and therefore, disclaims beneficial ownership over the SBC shares held by AEM, except to the extent of his pecuniary interest therein.

Footnote F3

Represents SBC shares held by Aikawa Investment Co., Ltd., a company wholly owned by the Reporting Person.